Series C funding round for Spero Therapeutics raising $52M in March 2017
Series C funding round for Spero Therapeutics raising $52M in March 2017
| Investor | Firm Type | Partner |
|---|
GVLEAD | Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Timothy A. Springer |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$155M
Top Valuation
-
Spero Therapeutics raised $52M in a Series C round.
The round was announced on 03/01/17.
The round was led by GV.